Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-155968

Options or other derivatives

  • Chief Financial Officer acquired 72,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ruffo Frank Chief Financial Officer 2016-12-15 Grant or award · Stock option (right to buy) +62,400 62,400 D: show line 1 in the form
Ruffo Frank Chief Financial Officer 2016-12-15 Grant or award · Restricted stock units +10,400 10,400 D: show line 2 in the form
Loading xslF345X03/doc4.xml…